Loading clinical trials...
Loading clinical trials...
The Effects of Extracorporeal Magnetic Innervation in Combination With Mirabegron in the Treatment of Urinary Frequency, Urgency and Urge Incontinence
Conditions
Interventions
mirabegron 50 mg daily
Extracorporeal magnetic innervation (active treatment)
+1 more
Locations
1
Slovenia
University Medical Centre Maribor
Maribor, Slovenia
Start Date
October 14, 2019
Primary Completion Date
April 3, 2023
Completion Date
October 1, 2023
Last Updated
November 9, 2023
NCT05362292
NCT07193407
NCT07195656
NCT05799313
NCT04873037
NCT05557279
Lead Sponsor
Serdinsek Tamara
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions